Clicks Group (CLS) Trading update summary
Event summary combining transcript, slides, and related documents.
Trading update summary
22 Jan, 2026Group performance
Group turnover rose 7.4% to R19.5 billion for the first 20 weeks of the 2026 financial year compared to the prior period.
Retail sales increased by 6.0%, with comparable store sales up 3.7% and selling price inflation averaging 2.4%.
Pharmacy turnover grew 9.0%, driven by strong demand, record Black Friday sales, and robust Christmas gifting sales.
Distribution turnover increased by 11.4%, supported by higher purchasing compliance and more pharmacy openings.
Operational highlights and challenges
Retail turnover was affected by aggressive competitor discounting and a warehouse management system delay in Cape Town, impacting sales by approximately R120 million.
Product availability in the Western Cape has improved and is expected to reach targets by February 2026.
UPD's notional turnover for bulk agency distribution clients declined 20.2% due to non-renewal of two contracts, resulting in a 0.2% decrease in total managed turnover.
Financial reporting and outlook
Interim results for the six months to 28 February 2026 are expected to be released on or about 23 April 2026.
Financial information in this update has not been reviewed or audited by independent auditors.
Latest events from Clicks Group
- EPS up 14.3%, turnover up 9.2%, and 2025 targets 40–50 new stores and pharmacies.CLS
H2 202418 Jan 2026 - HEPS up 13.2%, turnover up 6.2%, and 45–55 new stores planned amid strong cash flow.CLS
H1 202529 Nov 2025 - Strategic focus on store growth, omnichannel, and efficiency drives robust expansion and margins.CLS
Deutsche Bank ADR Virtual Investor Conference24 Nov 2025 - EPS up 14.1%, ROE at 49.2%, with strong cash flow and market share gains.CLS
H2 202523 Oct 2025